Logo image
Se connecter
A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance
Article de revue   Avec comité de lecture

A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance

Adam Abdullahi, Ana Garcia Diaz, Olga Mafotsing Fopoussi, Apostolos Beloukas, Victoire Fokom Defo, Charles Kouanfack, Judith Torimiro et Anna Maria Geretti
Journal of antimicrobial chemotherapy, Vol.79(2), pp.339-348
01/02/2024
PMID: 38153241

Résumé

Infectious Diseases Life Sciences & Biomedicine Microbiology Pharmacology & Pharmacy Science & Technology

Indicateurs

1 Consultations de la notice

Détails

Logo image